BMS 6072 (Glucovance 1.25 mg / 250 mg)
Generic Name: glyburide/metformin
Pill imprint BMS 6072 has been identified as Glucovance 1.25 mg / 250 mg.
Glucovance is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Glucovance 1.25 mg / 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- BMS 6072
- 1.25 mg / 250 mg
- 13.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Bristol-Myers Squibb
- National Drug Code (NDC):
- Inactive Ingredients:
- microcrystalline cellulose
|NDC Code||Manufacturer / Repackager|
|54868-4906||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
More about Glucovance (glyburide / metformin)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.